AAAAI News: Retreatment With Barzolvolimab Improves ColdU and SD Symptoms

Retreatment with barzolvolimab leads to rapid improvement in urticaria control after symptom recurrence, according to results from the Phase 2 ColdU and SD Open Label Extension (OLE) trial.